First City Capital Management Inc. reduced its stake in Becton, Dickinson and Company (NYSE:BDX) by 2.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,428 shares of the medical instruments supplier’s stock after selling 125 shares during the period. First City Capital Management Inc.’s holdings in Becton, Dickinson and were worth $812,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. First United Bank Trust raised its position in shares of Becton, Dickinson and by 7.8% in the first quarter. First United Bank Trust now owns 7,027 shares of the medical instruments supplier’s stock valued at $1,289,000 after buying an additional 510 shares during the period. Beese Fulmer Investment Management Inc. raised its position in shares of Becton, Dickinson and by 2.7% in the first quarter. Beese Fulmer Investment Management Inc. now owns 26,022 shares of the medical instruments supplier’s stock valued at $4,773,000 after buying an additional 688 shares during the period. Wealth Enhancement Advisory Services LLC raised its position in shares of Becton, Dickinson and by 188.1% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 26,494 shares of the medical instruments supplier’s stock valued at $4,881,000 after buying an additional 17,298 shares during the period. Carderock Capital Management Inc. raised its position in shares of Becton, Dickinson and by 0.5% in the first quarter. Carderock Capital Management Inc. now owns 13,499 shares of the medical instruments supplier’s stock valued at $2,476,000 after buying an additional 69 shares during the period. Finally, Pinnacle Bank acquired a new position in shares of Becton, Dickinson and during the first quarter valued at about $192,000. Institutional investors own 75.57% of the company’s stock.

Becton, Dickinson and Company (NYSE:BDX) traded up 0.57% during mid-day trading on Monday, hitting $201.50. 287,793 shares of the stock traded hands. The stock has a 50-day moving average price of $198.90 and a 200-day moving average price of $187.70. The stock has a market cap of $45.85 billion, a P/E ratio of 58.36 and a beta of 1.05. Becton, Dickinson and Company has a 12 month low of $161.29 and a 12 month high of $206.63.

Becton, Dickinson and (NYSE:BDX) last posted its quarterly earnings data on Thursday, August 3rd. The medical instruments supplier reported $2.46 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.44 by $0.02. The firm had revenue of $3.04 billion during the quarter, compared to analysts’ expectations of $3.06 billion. Becton, Dickinson and had a net margin of 6.25% and a return on equity of 22.53%. The firm’s quarterly revenue was down 5.1% on a year-over-year basis. During the same quarter last year, the company posted $2.35 EPS. On average, equities analysts forecast that Becton, Dickinson and Company will post $9.46 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 29th. Investors of record on Friday, September 8th will be given a dividend of $0.73 per share. The ex-dividend date of this dividend is Thursday, September 7th. This represents a $2.92 dividend on an annualized basis and a dividend yield of 1.46%. Becton, Dickinson and’s payout ratio is currently 83.43%.

COPYRIGHT VIOLATION WARNING: “First City Capital Management Inc. Sells 125 Shares of Becton, Dickinson and Company (NYSE:BDX)” was first published by Watch List News and is the property of of Watch List News. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of US and international copyright and trademark laws. The original version of this piece of content can be read at https://www.watchlistnews.com/first-city-capital-management-inc-sells-125-shares-of-becton-dickinson-and-company-nysebdx/1487166.html.

Several research analysts have issued reports on BDX shares. BidaskClub lowered Becton, Dickinson and from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. Bank of America Corporation restated a “buy” rating and set a $225.00 target price (up previously from $200.00) on shares of Becton, Dickinson and in a research report on Friday, July 21st. Zacks Investment Research upgraded Becton, Dickinson and from a “hold” rating to a “buy” rating and set a $225.00 target price for the company in a research report on Monday, July 17th. Stifel Nicolaus restated a “buy” rating on shares of Becton, Dickinson and in a research report on Wednesday, August 9th. Finally, Barclays PLC restated an “equal weight” rating and set a $210.00 target price (up previously from $205.00) on shares of Becton, Dickinson and in a research report on Thursday. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $195.79.

In related news, insider Ellen R. Strahlman sold 9,283 shares of the stock in a transaction that occurred on Thursday, August 10th. The shares were sold at an average price of $198.21, for a total transaction of $1,839,983.43. Following the completion of the transaction, the insider now owns 26,638 shares of the company’s stock, valued at approximately $5,279,917.98. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Jeffrey S. Sherman sold 28,765 shares of the stock in a transaction that occurred on Thursday, May 25th. The stock was sold at an average price of $185.98, for a total transaction of $5,349,714.70. Following the transaction, the vice president now directly owns 70,821 shares of the company’s stock, valued at approximately $13,171,289.58. The disclosure for this sale can be found here. Insiders have sold a total of 44,019 shares of company stock valued at $8,368,433 in the last ninety days. 1.40% of the stock is currently owned by corporate insiders.

Becton, Dickinson and Company Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX).

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with Analyst Ratings Network's FREE daily email newsletter.